Gramercy Extremity Orthopedics® Receives US Patent for Variable Angle Locking Technology

DALLAS, TX, USA, September 24, 2018 /EINPresswire.com/ — Gramercy Extremity Orthopedics (GEO®) receives US Patent No. 10,058,362 which covers a novel approach for Variable Angle Locking Technology. It provides various methods for taking advantage of the strength of machined threads in both the plate and screw by using inserts in the plate that allow the screw to be fixed at various angles and orientations. In the main embodiment, an insert can be attached to the end of a drill guide which also serves to orient and attach the insert to the plate. Once in place, the drill hole is made in perfect alignment with the screw hole in the insert. The insert contains machined threads just as a standard plate hole would, allowing a standard locking screw to be inserted at the desired orientation. The screw can also be easily removed, the insert re-oriented, and the screw replaced as desired.

“The granting of this US patent further enhances GEO’s ability to bring solutions to surgeon needs in the orthopedic marketplace”, says Michael P. Simpson, CEO and President of GEO®. “This technology will compliment future development projects while adding additional technology to the GEO CART®”

GEO® will be exhibiting at the Becker’s ASC Conference, Chicago, October 18th– October 19th, 2018. Please come see the GEO CART® and other GEO® offerings at Booth #15T.

About GEO®:

GEO® was founded on the idea that there could exist a more cost effective, user-friendly way to supply orthopedic medical implants in today’s healthcare environment. This is accomplished through the use of technology, a groundbreaking Point-of-Sale delivery system and GEO® designed sterile, single use disposable orthopedic implants and instruments. GEO is the only solution that provides a significant opportunity to lower real operating costs by creating efficiencies and controls throughout the delivery and consumption of orthopedic implants.


Press Media Contact:

Michael Nugent
Gramercy Extremity Orthopedics
855-436-2278 x103
email us here

Powered by EIN Presswire

OrthoPediatrics Corp. Announces First PNP | FEMUR Cases Performed in Australia

WARSAW, Ind., Sept. 17, 2018 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce the first surgeries in Australia utilizing the new Pediatric Nailing Platform | FEMUR (“PNP | FEMUR”).  OrthoPediatrics’ sales agent in Australia and New Zealand is Surgical Specialties, headquartered in Frenchs Forest, New South Wales.

Joe Hauser, OrthoPediatrics’ Vice President of Trauma & Deformity Correction, stated, “We are extremely pleased by the success of the first PNP|FEMUR cases in Brisbane. Our new pediatric nailing system continues to better serve the unique complexity associated with pediatric anatomy, and we are delighted that we are able to bring this innovative technology to pediatric orthopedic surgeons and their patients in Australia.”

The PNP | FEMUR system is designed for use in pediatric and small stature adult patients to address femoral shaft fractures, subtrochanteric femur fractures, ipsilateral neck/shaft fractures, prophylactic nailing of impending pathologic fractures, nonunions, malunions, and fixation of femurs that have been surgically prepared (osteotomy) for correction of deformity.

Dr. Geoff Donald, the orthopedic surgeon who performed the first cases, commented, “All aspects have gone smoothly in my first cases utilizing OrthoPediatrics’ innovative new system.  We performed a rotational femoral osteotomy to correct severe out-toeing gait, as well as a femoral shaft fracture with flawless instrumentation performance.  We look forward to utilizing the exceptional system in more procedures.”

About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 25 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This offering spans trauma & deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and 38 countries outside the United States.

About Surgical Specialties
OrthoPediatrics’ sales agent, Surgical Specialties, is an independent distributor of innovative medical devices to the Australian and New Zealand medical community. The business focuses on the following surgical areas: Arthroplasty, Extremities, Specialty Trauma, Orthobiologics, Critical Care and Operating Room Products.  Established in 2006, Surgical Specialties now has a team of over 70 professionals, with sales offices throughout Australia and New Zealand.  To learn more about Surgical Specialties, visit: http://www.surgicalspecialties.com.au/

Investor Contacts
The Ruth Group
Tram Bui / Emma Poalillo
(646) 536-7035 / 7024
tbui@theruthgroup.com / epoalillo@theruthgroup.com

AMDT Holdings, Inc. Gains FDA Clearance for the SixFix™ System

COLLIERVILLE, Tenn.Sept. 5, 2018 /PRNewswire/ — AMDT Holdings, Inc. (AMDT) is pleased to announce FDA clearance for their patented SixFix deformity analysis and correction software and instrumentation. AMDT Holdings, Inc. develops new products to address the existing and emerging needs of the multi-billion-dollar extremity medical device market.

Spatial frame fixators usually consist of two rings connected by six adjustable connectors called struts. This type of construct can also be referred to as a hexapod. Fixation elements connect the rings to bone fragments; small, simultaneous changes in the lengths of multiple struts alter the alignment of the bone fragments in relation to one another. Currently, surgeons manually measure and input values, many derived from patient radiographs, into optional software to create a prescription consisting of daily adjustments over a period of weeks or months. The end result is a corrected deformity and a healed fracture.

The SixFix system, which is indicated for use with the Smith & Nephew Taylor Spatial Frame®, dramatically reduces the time and effort involved in manual input of measurements and their values as required by currently available alternatives, and generates a prescription defining the incremental strut adjustments that will ultimately correct the deformity.

With the SixFix system, the surgeon attaches the system’s six radiopaque fiducial markers to the rings of a spatial frame external fixator, and inputs readily available spatial frame characteristics, such as ring diameter, strut length and axial rotation, into the SixFix software. This information is used to graphically map the deformity with line segments that define the axes of the bone fragments. The software utilizes sophisticated algorithms to correct imperfections present in all radiographs, such as variable magnification and perspective distortion, in the process of creating a precise 3-D replica of the frame and the deformity. SixFix software offers the surgeon options to specify waypoints, customized treatment milestones that the surgeon uses to set the order and duration of each correction.

“This is truly a medical innovation that can offer advantages to both my patients and me,” says Paul Freudigman, M.D. An orthopedic surgeon in the Dallas-Fort Worth, TX, area who has treated patients with spatial frames for almost 20 years, Freudigman is eager to utilize the SixFix technology. “The reduction in time and effort to generate a deformity correction prescription using SixFix is remarkable. Even more exciting will be to assess how much the image correction capabilities of the software can improve my outcomes.”

Stephen J. Frania, DPM, FACFAS, a surgeon in Mentor, Ohio, who specializes in reconstructive foot and ankle surgery including lower limb deformity correction, says, “Of all the advantages offered by the SixFix software, time-savings is one benefit that I will realize right away.” He goes on to explain, “The current devices require a great deal of time and manual effort during my clinic hours to measure and record the data necessary to describe the frame and the deformity as represented by their radiographs. I bring these patients in weekly to evaluate the progress of their correction. The time I save and the improved accuracy when using the SixFix software is significant over these repeat visits.”

Samir Mehta, M.D., Chief of Orthopaedic Trauma and Fracture Service for the University of Pennsylvania Health System, who is at the forefront of fracture fixation and deformity correction, also expresses interest in the benefits the SixFix system provides. “The intuitive, graphical nature of the SixFix software reduces my time and effort when treating a deformity. In addition, it works with one of the devices I currently use. The end result is a deformity correction prescription requiring surprisingly little manual input and time.”

The SixFix system was developed under the direction of Michael Mullaney, VP of Product Development at AMDT Holdings, Inc., who created the web-based implementation of the forward kinematic solution that solved the challenge of the crooked frame on a crooked bone when the Smith & Nephew Taylor Spatial Frame® was first widely used. In reference to the SixFix system, Mullaney says, “The six radiopaque markers provide full descriptive positional data to the SixFix software that enable it to create an accurate 3-D replica of the frame and deformity regardless of how the radiographic images were taken. The SixFix is a far more powerful and accurate tool than my prior deformity correction application as well as more intuitive, faster and easier-to-use.”

Patrick Mullaney, President and CEO of AMDT Holdings, Inc., has also been involved in this segment of orthopaedic devices since its inception in the mid-1990s. “While the SixFix software represents significant advantages in ease-of-use to the surgeon, these major benefits will be compounded with the introduction of a truly innovative hexapod that is currently in development. Initial test results of the hexapod are impressive. We plan to submit this 510(k) application to FDA shortly.”

Since its inception in 2016, AMDT has been focused on designing, validating and commercializing innovative devices to address challenges faced by surgeons treating fractures and correcting deformities. Headquartered outside of Memphis in Collierville, Tennessee, AMDT also commercialized the AMDT Mini-Rail Fixator in early 2017, a modular unilateral external fixator that provides versatile fixation for simple or complex trauma, deformity correction and lengthening procedures. Arrowhead Medical Device Technologies, LLC, the sister organization to AMDT, was founded in 2010 to commercialize the patented ARROW-LOK® Digital Fusion System. Designed to effectively correct digital deformities of the foot, it has the distinction of being the world’s tiniest intramedullary nail. To learn more about AMDT, SixFix and the AMDT Mini-Rail Fixator, please visit www.AMDTHoldings.com. The ARROW-LOK can be viewed at www.ArrowheadDevices.com.

SixFix is a trademark of AMDT Holdings, Inc.
ARROW-LOK is a registered trademark of Arrowhead Medical Device Technologies, LLC.
Taylor Spatial Frame is a trademark of Smith & Nephew, Inc.

CisionView original content:http://www.prnewswire.com/news-releases/amdt-holdings-inc-gains-fda-clearance-for-the-sixfix-system-300707520.html

SOURCE AMDT Holdings, Inc.

WishBone Medical, Inc. announces new AlloMate Bone Pin System

WARSAW, Ind., Sept. 05, 2018 (GLOBE NEWSWIRE) — WishBone Medical, Inc. announces the official launch of the single-use, sterile packed AlloMate Bone Pin System for the maintenance of alignment and fixation of bone fractures, osteotomies, arthrodesis or bone grafts and may also be used to fill a void left after screw removal.

The AlloMate Bone Pin System consists of allograft bone pins and accessory instrumentation for quick, reliable and reproducible bone pin insertion. The complete system will be available in five different individual sizes (2.0mm, 2.5mm, 3.0mm, 3.5mm, and 4.0mm) of sterilized human cortical bone pins & corresponding single-use instruments for convenient insertion. We will launch these various sizes in stages. The 3.0mm is currently available and the 2.5mm will be available soon followed by the 2.0mm and the additional sizes. Our initial market feedback with the 3.0mm system has been extremely positive.

These bone pins are sturdy, easy to handle and can integrate into the patient’s bone to help with the healing process. These sterile packed implants and instruments may potentially reduce the risk of infection and can be accurately trimmed intraoperatively to an appropriate length.

Daniel S. Schulman, D.P.M., helped develop this system and he said, “I have performed well over four hundred foot reconstructive procedures without the use of a metal implant. I can validate that this system will definitely simplify the surgical technique and minimize intra-operative and post-operative surgical complications. Patients are elated when they are told there will be no need for a second surgery to remove potentially painful, broken or even infected hardware.”

Nick Deeter, Chairman of the Board and CEO at WishBone Medical, said, “The AlloMate Bone Pin System does help minimize the need for removal in a secondary operation to remove hardware like stainless steel wires.” Mr. Deeter added, “Minimizing the number or surgeries for kids is very important to us.”

About WishBone Medical, Inc.

WishBone Medical is a Global pediatric orthopedic company, committed to providing anatomically appropriate innovative implants and instruments in sterile packed, single use, disposable kits to prevent infection, reduce overall costs for our customers and achieve the best outcomes for children around the world who are still growing.

For further information, email CustomerService@WishBoneMedical.com or call at 574-306-4006. To learn more about WishBone Medical visit www.WishBoneMedical.com or contact Andrew Miclot, Vice-Chairman and President.

Paragon 28® adds novel syndesmotic repair solution to its robust ankle fracture portfolio – Gorilla® Breakaway Screw System

ENGLEWOOD, Colo.Aug. 31, 2018 /PRNewswire/ — Since its inception, Paragon 28® has obsessed over every aspect of foot and ankle surgery. Committed to creating tailored solutions to improve surgical outcomes, Paragon 28® has launched innovative products and instrumentation that help to streamline procedures, allow surgeons flexibility in technique and approach, and facilitate reproducible results benefitting both the surgeon and patient.

The Paragon 28® Gorilla® Breakaway Screw System was designed to offer surgeons an improved design over traditional screws when used for syndesmotic fixation.

There are inherent challenges in addressing syndesmotic repair including:

  • Providing stable fixation while the syndesmosis heals
  • Soft tissue irritation
  • Screw fracture and removal of fractured implants

The Gorilla® Breakaway Screw System was designed with these challenges in mind. A rigid construct allows the syndesmosis to heal while a low-profile head limits soft tissue irritation. While broken and loose screws have demonstrated improved patient outcomes as compared to intact syndesmotic screws1, the location of screw breakage can be unpredictable with some breakage causing osteolysis from adjacent bony erosion leading to pain and difficult removal.2

The Breakaway Screw System was designed so that if screw fracture occurs, the screw breaks cleanly in the clear space at the notch point. Multiple removal features allow the surgeon to remove the screw fragments medially or laterally, if necessary.

Two notch lengths (14 and 17 mm) were designed to address differences in patient anatomy and to accommodate screw use with or without a plate. The notch is designed to be placed in the clear space when used for syndesmosis repair.

If removal is desired, the tibial component of the Breakaway Screw may be removed medially or laterally utilizing dedicated removal instrumentation.

Paragon 28® is grateful for the significant contributions Dr. John Kwon, MD and Dr. Matthew Riedel, MD have made as the surgeon designers of this system.

About Paragon 28, Inc.

Paragon 28, Inc. was established in 2010 to address the unmet and under-served needs of the foot and ankle community. From the onset, Paragon 28 has made it our goal to re-invent the space of foot and ankle surgery. We believe that through research and innovation we can create new and improved solutions to the challenges faced by foot and ankle specialists.

1. Manjoo A, Sanders DW, Tieszer C, Macleod MD. Functional and radiographic results of patients with syndesmotic screw fixation: implications for screw removal.

J Orthop Trauma. 2010;24:2-6

2. Riedel MD, Briceno J, Miller C, Kwon J Technical tip: Removal of a broken tri-cortical syndesmotic screw using a “perfect circle” technique. Injury. 201 B Apr;49(4):877-880. doi: 10.1 016/j.injury.2018.02.022. Epub 2018 Mar 2.

Product Page:



Jim Edson



SOURCE Paragon 28, Inc.

Photo: PRNewsfoto/Paragon 28, Inc

Related Links


EOS imaging Installs Its First Site in Mexico

September 04, 2018

EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI – Eligible PEA – PME), the pioneer of 2D/3D imaging and data solutions for orthopedics, today announced the first installation of an EOS® system in Mexico, the largest Central American market, at Shriners Hospitals for Children – Mexico, located in Mexico City.

“Shriners Hospitals for Children – Mexico, noted for excellent pediatric specialty care, modern medical technology and exceptional personnel, is proud to bring the EOS technology to our facility,” said Dr. Mariano Gonzalez Lugo, Hospital Administrator. “The ability to obtain full-body, weight-bearing images of our patients will further enhance the orthopedic care we provide. In addition, the EOS system produces images with far less patient exposure to radiation than conventional X-rays. Our patients deserve safe, quality imaging and this is an important step in the right direction.”

Established in 1945, Shriners Hospital for Children – Mexico today has 80 beds and four operating rooms to treat patients up to 18 years of age for general pediatric orthopedics including upper- and lower-extremity surgeries, spine surgeries and bone lengthening and correction surgeries.

We applaud the Shriners Hospitals for Children for their commitment to safe imaging and are excited to see our footprint expand into Mexico,” commented Marie Meynadier, CEO of EOS imaging. “This is the first facility to adopt our system in Mexico City, serving more than 12 million inhabitants. It marks a significant step towards making our solutions available to Central American patients and healthcare providers.”

About EOS imaging

EOS imaging designs, develops and markets EOS®, a major innovative medical imaging solution dedicated to osteo-articular pathologies and orthopedics combining equipment and services and targeting a $2B per year market opportunity. EOS imaging is currently present in 31 countries, including the United States under FDA agreement, Japan, China and the European Union under CE labelling, through the over 250 installed EOS® platforms representing around one million patient exams every year. Revenues were €37.1M in 2017, e.g. a +32% CAGR over 2012-2017.

For more information, please visit www.eos-imaging.com.

EOS imaging has been selected to integrate the EnterNext © PEA – PME 150 index, composed of 150 French, listed companies on the Euronext markets in Paris.

EOS imaging is listed on Compartment C of Euronext Paris
ISIN: FR0011191766 – Ticker: EOSI


EOS imaging
Marie Meynadier, +33 (0)1 55 25 60 60
Press Relations (US)
The Ruth Group
Kirsten Thomas, 508-280-6592
Investor Relations (US)
The Ruth Group
Matt Picciano / Emma Poalillo, 646-536-7008 / 7024

Stimwave Names Industry Veterans Paul LaViolette and Jeffrey Goldberg to Board of Directors

August 23, 2018

POMPANO BEACH, Fla.–(BUSINESS WIRE)–Stimwave LLC, a medical device manufacturer and independent research institute headquartered in South Florida, announced today that Paul LaViolette, managing partner and chief operating officer of SV Health Investors and former COO of Boston Scientific, and Jeff Goldberg, former president of Al Mann’s medical-technology incubator, joined Stimwave’s Board of Directors.

“Paul is an inspirational thought leader who has helped grow companies who were disruptive in health care into multi-billion dollar enterprises, while improving the lives of millions,” said Stimwave Chairman and CEO of Laura Tyler Perryman. “He will be an outstanding addition to our board.”

LaViolette built and ran medical device businesses for 29 years, and he was chief operating officer at Boston Scientific (BSC). During his tenure, the company grew revenue over 20 times. He integrated two dozen acquisitions and led extensive product development, manufacturing and worldwide commercial organizations.

“It’s an honor and a privilege to come aboard with Stimwave as it deploys its innovative technology to market,” said LaViolette. “Medical devices focused on increased access, minimal invasiveness and state of the art technology are the future of health care, and Stimwave is well positioned to expand the neuromodulation market.”

“Jeff Goldberg served a critical role within Al Mann’s enterprises for many years, and Stimwave holds the same principles of creating a technology platform that can benefit patients’ lives, while increasing the market considerably by reimagining how we deliver neuromodulation,” said Perryman. “Familiarity with industry disruptor products such as Stimwave will be invaluable to our future growth plans as we continue to transform our business at an accelerated pace.”

Goldberg has been an executive and advisor in the health care industry for over 25 years. Recently, he served as chair of the board of Angiotech Pharmaceuticals and Physiotherapy Associates and is now serving as chair of the board of 21st Century Oncology, LifeCare Health Partners, Corizon Health, and M*Modal.

“The opportunity to treat pain without implanting a large battery, like what Laura and the Stimwave team are offering patients and their physicians, represents the same type of dramatic innovation that characterized Al Mann’s most successful companies,” Goldberg said. “I am honored to work with as creative and dynamic a leader with Laura and look forward to our journey together.”

Stimwave’s devices are the premier wireless stimulators, using Wireless Pain Relief® technology that allows them to be 95 percent smaller than any other neuromodulation device on the market. These devices treat back and leg pain, as well as treatment for shoulder pain, wrist and elbow pain, knee pain, hip pain and more.

About Stimwave LLC

Stimwave LLC is a privately held medical device company engaged in the development, manufacturing, and commercialization of wirelessly powered, microtechnology neurostimulators, providing patients with a convenient, safe, minimally invasive, and highly cost-effective pain management solution that is easily incorporated into their daily lives. Stimwave’s goal is to evolve its patented, cutting-edge platform into the default for neuromodulation, increasing the accessibility for patients worldwide while lowering the economic impact of pain management. www.stimwave.com


Glodow Nead Communications
Lori Puccinelli Stern, Rosemary O’Brien and Sarah Rodgers, 415-394-6500

Rush Orthopaedic Program Ranked No. 4 in the U.S.; Top in Illinois

CHICAGOAug. 14, 2018 /PRNewswire/ — U. S. News & World Report released its 2018-2019 Best Hospitals National Ranking and the Department of Orthopaedic Surgery at Rush University Medical Center (RUMC), consisting of Midwest Orthopaedics at Rush (MOR) physicians, moved from the fifth to the fourth best orthopedic program in the nation. The report also continues to honor RUMC/MOR as the highest ranked orthopedic program in Illinois.

OrthoPediatrics Corp. Announces Expansion of its Warsaw Headquarters

WARSAW, Ind., Aug. 14, 2018 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today the expansion of its Warsaw, Indiana headquarters. The planned $1M expansion will double the Company’s existing warehouse while creating additional open-concept office space and dedicated training and education facilities.

The Company will host a ground-breaking ceremony on Thursday, August 16th, at 2:00pm ET.

The Indiana Economic Development Corporation (IEDC) is a great supporter of this initiative, adding “Indiana is known as one of the leading hubs for orthopedics, and we are excited to see this trend not only continue but strengthen with the commitment of companies like OrthoPediatrics,” said Elaine Bedel, IEDC President. “Our industry leaders are innovating new products and developing 21st century solutions for people in need across the world, while serving Hoosiers and their families here at home by providing good, skilled jobs. We are glad that OrthoPediatrics is choosing to expand here in Indiana, and we can’t wait to see what’s next for this growing team.”

Mark Throdahl, Chief Executive Officer of OrthoPediatrics, commented, “For the last 10 years, OrthoPediatrics has grown revenue 20% or more every year, and we reported 28% revenue growth last quarter.  Since our IPO in October 2017, we have been aggressively investing in growth initiatives, including hiring additional associates, tripling the deployment of consigned implant/instrument sets, increasing our investment in R&D, and expanding our clinical education programs.  With all the exciting opportunities we are pursuing, we have simply outgrown our current building! The physical expansion of our headquarters reflects OrthoPediatrics’ growth and commitment to our surgeons and their patients so we can continue strengthening our leadership in pediatric orthopedics.”

About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 25 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This offering spans trauma & deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and 38 countries outside the United States.

Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of U.S. federal securities laws. You can identify forward-looking statements by the use of words such as “may,” “might,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “believe,” “estimate,” “project,” “target,” “predict,” “intend,” “future,” “goals,” “potential,” “objective,” “would” and other similar expressions. Forward-looking statements involve risks and uncertainties, many of which are beyond OrthoPediatrics’ control. Important factors could cause actual results to differ materially from those in the forward-looking statements, including, among others, the risks, uncertainties and factors set forth under “Risk Factors” in OrthoPediatrics’ Annual Report on Form 10-K filed with the SEC on March 15, 2018. Forward-looking statements speak only as of the date they are made. OrthoPediatrics assumes no obligation to update forward-looking statements to reflect actual results, subsequent events, or circumstances or other changes affecting such statements except to the extent required by applicable securities laws.

Investor Contacts
The Ruth Group
Tram Bui / Emma Poalillo
(646) 536-7035 / 7024
tbui@theruthgroup.com / epoalillo@theruthgroup.com

HSS Ranked No. 1 in Orthopedics by U.S. News & World Report for Ninth Consecutive Year

NEW YORKAug. 14, 2018 /PRNewswire/ — For the ninth consecutive year, Hospital for Special Surgery (HSS) has been ranked the No. 1 hospital in the nation for orthopedics by U.S.News & World Report “Best Hospitals 2018-2019” survey. HSS was also recognized as a leader in the field of rheumatology, maintaining the No. 3 ranking in the country. This is the 27th consecutive year HSS has been among the top rated hospitals.

“We are fully committed to our singular focus on musculoskeletal health which allows us to not only provide the highest quality of care and value but also to be a leader in the field through innovation,” said Louis A. Shapiro, president and CEO of HSS. “We are invested in helping people move better so they can live better.”

For the 2018-19 rankings, U.S. News evaluated more than 4,500 medical centers nationwide in 25 specialties, procedures and conditions. In the 16 specialty areas, 158 hospitals were ranked in at least one specialty.

“Whether it’s a routine or complex case, our patients benefit from highly specialized physicians with the shared goal of delivering an unmatched level of personalized care to each patient,” said Todd J. Albert, MD, surgeon-in-chief and medical director of HSS. “It is truly an honor to be a part of such a dedicated, patient-centric medical staff.”

In 2017, HSS cared for over 135,000 pediatric and adult patients surgically and non-surgically for conditions including joint pain, trauma and sports injuries, osteoarthritis, rheumatoid arthritis, back pain and spinal disorders, and conditions of the hand and upper extremity, and foot and ankle.

“Rheumatic and autoimmune diseases often present as diagnostic puzzles, and medical management can be challenging,” said Mary K. Crow, MD, physician-in-chief and chief of the Division of Rheumatology. “The chronic nature of these disorders requires sustained attention and a personal approach to care. I am regularly impressed at the level of specialized expertise that our outstanding rheumatologists provide for these complex patients and the coordinated teamwork and commitment of our HSS staff that optimizes patient outcomes and quality of life.”

HSS also provides care to elite, professional and collegiate athletes and organizations around the world, including USABasketball, Fédération Internationale de Football Association (FIFA), UFC, the Brooklyn Nets, New York Giants, New York Knicks, New York Mets and New York Red Bulls, among others.

About HSS | Hospital for Special Surgery

HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the ninth consecutive year) and No. 3 in rheumatology by U.S. News & World Report (2018-2019). Founded in 1863, the Hospital has one of the lowest infection rates in the country and was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. The global standard total knee replacement was developed at HSS in 1969. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New JerseyConnecticut and in the Long Island and Westchester County regions of New York State. In 2017 HSS provided care to 135,000 patients and performed more than 32,000 surgical procedures. People from all 50 U.S. states and 80 countries travelled to receive care at HSS. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. The HSS Global Innovation Institute was formed in 2016 to realize the potential of new drugs, therapeutics and devices. The culture of innovation is accelerating at HSS as 130 new idea submissions were made to the Global Innovation Institute in 2017 (almost 3x the submissions in 2015). The HSS Education Institute is the world’s leading provider of education on the topic on musculoskeletal health, with its online learning platform offering more than 600 courses to more than 21,000 medical professional members worldwide. Through HSS Global Ventures, the institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally.

SOURCE Hospital for Special Surgery